Executive record

Jeffrey G. Lamothe

President, Chief Executive Officer and Director at Aptevo Therapeutics Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:jeffrey-g-lamotheVersion: public-0As of: 2026-09-29

Not yet claimed9 published Claims3 sources
  • Executive
  • Director

Key Claims

Biography

25+ year career spanning multiple industries in CEO, COO and CFO roles. Previously served as EVP and Chief Financial Officer at Aptevo, Vice President Finance at Emergent BioSolutions, and Chief Financial Officer at Cangene Corporation.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedPresident and Chief Executive Officer · Aptevo Therapeutics Inc.
  2. 2026 to end not publishedExecutive title: Executive Vice President and Chief Operating Officer · Organization not publishedAPVO 10-K executive officers
  3. Dates not publishedExecutive title: President and Chief Executive Officer · Organization not published

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Aug 31, 2026 · Retrieved: Sep 5, 2026

    Supports 3 claims
    • Professional Role: President and Chief Executive Officer at Aptevo Therapeutics Inc. · Claim reviewed: Sep 5, 2026
    • Professional Role: President, Chief Executive Officer and Director at Aptevo Therapeutics Inc. · Claim reviewed: Sep 5, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: Sep 5, 2026

  2. APVO 10-K executive officers

    sec filing · Source published: Mar 26, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Aptevo Therapeutics Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Executive Vice President and Chief Operating Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Aptevo Therapeutics Inc. · Claim reviewed: Sep 5, 2026